INSIGHTS ON UPSTREAM MANUFACTURING
-
Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors
Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.
-
Develop Clones In Just 9 Weeks From Transfection With Up To 4X Titer
Transposon-based cell line development cuts timelines by 10 weeks and hits titers of 4.8 g/L in 17 days. See how SynWeave delivers measurable biologics manufacturing gains.
-
Direct Scale Up From Clone To 2K GMP Batches
N-1 perfusion technology increased antibody titers 1.5–4.5x over conventional fed-batch methods. See how high seed density and media blending cut costs and maximize suite utilization.
-
Leveraging Integrated Media Services For Speed And Efficiency
Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.
-
Enabling Clinical-Grade Automated Manufacturing Of γδ T Cells6/12/2026
Explore smarter approaches to γδ T cell manufacturing, including scalable expansion, efficient transduction, and streamlined analytics, as well as how to build workflows that support validation.
-
Establishing The First Chinese Haplobank Of Clinical-Grade hiPSCs6/11/2026
Learn how automated, closed workflows and GMP-ready infrastructure are advancing pluripotent stem cell development from scalable expansion and differentiation to building regional capacity.
-
Achieving Clinical Quality For Human iPSC Generation And Expansion6/11/2026
Gain practical insight into building scalable stem cell manufacturing processes while maintaining consistency and quality across workflows, as well as in-depth guidance to support your strategy.
-
Automated GMP-Compliant PSC Banking In A Closed System6/11/2026
Explore advances in automated adherent cell culture and the optimization of large-scale iPSC expansion, as well as how standardization and process control are improving reproducibility.
UPSTREAM MANUFACTURING SOLUTIONS
-
See early-stage CDMO capabilities at a specialized bio campus, detailing process development, analytical support, bioconjugation services, cell banking, and scalable manufacturing solutions.
-
Bioprocessing is at the heart of many industries and Eppendorf has the right solutions for all of them.
-
Higher cell density and improved process consistency start with the right growth environment. This structured cell attachment helps streamline scale-up with unique protection to maintain strong viability across demanding bioprocess applications.
-
Flexible bioprocess control enables seamless transitions from development to scale, combining automation, intuitive operation, and precise environmental management to improve efficiency, reproducibility, and adaptability.
-
Modern bioprocessing depends on adaptable, precise equipment that supports scalability and consistency. Discover how to streamline workflows, reduce risk, and maintain control across up- and downstream operations.